Detailed results of the Phase 1b/2 trial of TG4001 and avelumab in advanced HPV-positive cancers presented at SITC 2020
By Lucie Larguier|2020-11-12T16:56:01+01:00November 12th, 2020|Webcast|Comments Off on Detailed results of the Phase 1b/2 trial of TG4001 and avelumab in advanced HPV-positive cancers presented at SITC 2020
About the Author: Lucie Larguier
